Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
04/2012
04/24/2012US8163902 Prodrugs of 2,4-pyrimidinediamine compounds and their uses
04/24/2012US8163901 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
04/24/2012US8163785 Pyrazolo[5,1b]oxazole derivatives as CRF-1 receptor antagonists
04/24/2012US8163753 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria
04/24/2012CA2480113C Substituted amino isoxazoline derivatives and their use as anti-depressants
04/24/2012CA2431557C Derivatives of streptogramins, their preparation and compositions containing them
04/24/2012CA2408752C Delivery systems for treatment of vascular disease
04/19/2012WO2012049190A1 N-pyridin-3-yl or n-pyrazin-2-yl carboxamides
04/19/2012WO2012048411A1 Plk-4 inhibitors and method of treating cancer with same
04/19/2012WO2011077098A9 Inhibitors of akt activity
04/19/2012US20120094993 N-pyridin-3-yl or n-pyrazin-2-yl carboxamides
04/19/2012US20120094989 5-ht receptor modulating compounds
04/19/2012US20120094983 Acyclic ikur inhibitors
04/19/2012US20120093891 Macrocyclic lactone compounds and methods for their use
04/19/2012US20120093767 Compounds for the Treatment of Hepatitis C
04/19/2012US20120093766 Compounds for the Treatment of Hepatitis C
04/19/2012CA2814688A1 Heteroaryls and uses thereof
04/19/2012CA2813520A1 N-pyridin-3-yl or n-pyrazin-2-yl carboxamides
04/19/2012CA2812779A1 Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
04/18/2012EP2440533A1 Guanine riboswitch binding compounds and their use as antibiotics
04/18/2012EP2440295A1 Benzimidazole derivatives useful as trpm8 channel modulators
04/18/2012EP2440294A1 Benzimidazole derivatives useful as trpm8 channel modulators
04/18/2012EP2440054A1 Pyridil-triazine inhibitors of hedgehog signaling
04/18/2012EP1409467B1 A n-acylsphingosine glucosyltransferase inhibitor
04/18/2012CN102421784A 作为gsk-3抑制剂的7-环烷基氨基喹诺酮 As gsk-3 inhibitor 7-cyclic alkyl amino quinolone
04/18/2012CN102417508A 作为新陈代谢调节剂的稠合芳基和杂芳基衍生物以及预防和治疗与其相关的病症 A fused aryl and heteroaryl metabolic modulators aryl derivatives and the prevention and treatment of disorders associated therewith
04/18/2012CN102417480A Spirocyclic nitriles as protease inhibitors
04/18/2012CN102417464A 肾素抑制剂的替代合成方法及其中间体 Renin inhibitors and intermediates alternative synthesis method
04/17/2012US8158797 Oxazolidinone-quinolone hybrid antibiotics
04/17/2012US8158781 Polymorphic forms α, β and γ of rifaximin
04/17/2012US8158648 Heteroaryl 11-beta hydroxysteroid dehydrogenase type I inhibitors
04/17/2012US8158621 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
04/17/2012US8158617 Fused heterocyclic compound and use thereof
04/17/2012CA2695291C Substituted bicyclolactam compounds
04/17/2012CA2491680C Inhibitors of ftsz and uses thereof
04/17/2012CA2469138C Inhibitors of cytosolic phospholipase a2
04/12/2012WO2012048129A2 Inhibitors of polo-like kinase
04/12/2012WO2012006104A3 Compounds and methods for treating tuberculosis infection
04/12/2012US20120088770 Alpha helix mimetics and methods relating thereto
04/12/2012US20120088755 Novel Compounds
04/12/2012US20120088748 Heterocyclic compounds
04/11/2012EP2437600A1 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
04/11/2012CN102408436A 一种卟啉-冠醚化合物及其合成和应用 One kind of porphyrin - crown ether compounds and their synthesis and applications
04/11/2012CN102408435A 一种从链霉菌发酵液中提纯子囊霉素的方法 A method of purifying the fermentation broth of Streptomyces ascomycin
04/11/2012CN102408434A 防指纹污染化合物 Anti-fingerprint contamination compound
04/11/2012CN102408419A 苯并噁嗪树脂、其制备方法及以其为原料制成的无卤无磷阻燃覆铜板用浸渍胶 Benzoxazine resin, its preparation and its raw materials made of halogen-free phosphorus-free flame-retardant laminates impregnated with glue
04/11/2012CN101490060B Mtki喹唑啉衍生物 Mtki quinazoline derivatives
04/11/2012CN101379044B 用于治疗糖尿病的杂双环磺酰胺衍生物 For the treatment of diabetes heterobicyclic sulfonamide derivatives
04/10/2012US8153652 Fab I inhibitors
04/10/2012US8153647 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
04/10/2012US8153150 Methods of administering tetrazole-containing rapamycin analogs with other therapeutic substances for treatment of vascular disorder
04/10/2012CA2549147C Tricyclic 1-((3-indol-3-yl)carbonyl) piperazine derivatives as cannabinoid cb1 receptor agonists
04/10/2012CA2486308C Hepatitis c virus inhibitors
04/05/2012WO2012043791A1 1,2,4-triazolone derivative
04/05/2012WO2012043505A1 Novel piperidine derivative and pharmaceutical containing same
04/05/2012WO2012041227A1 Tetracyclic heterocycle compounds for treating hepatitis c viral infection
04/05/2012WO2012041014A1 Tetracyclic indole derivatives for treating hepatitis c virus infection
04/05/2012WO2012024419A3 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
04/05/2012US20120083557 Sterically hindered amine stabilizers
04/05/2012US20120083476 Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase
04/05/2012CA2811662A1 Tetracyclic indole derivatives for treating hepatitis c virus infection
04/05/2012CA2811192A1 1,2,4-triazolone derivative
04/04/2012EP1615878B1 Compounds, compositions and methods of treatment for heart failure
04/04/2012EP1557418B1 Quinoxaline derivatives
04/04/2012CN102405223A 利福霉素衍生物 Rifamycin derivative
04/03/2012US8148540 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
04/03/2012US8148529 Pyrrolo[3,2-C] pyridine derivatives and processes for the preparation thereof
04/03/2012US8148395 Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
04/03/2012US8148370 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[1,2-a]pyridines, and preparation and therapeutic use thereof
04/03/2012CA2674369C Fused substituted aminopyrrolidine derivative
04/03/2012CA2566464C Synthesis of tetracyclines and analogues thereof
04/03/2012CA2554187C 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines compound
03/2012
03/29/2012WO2011123524A3 Macrolide inhibitors of mtor
03/29/2012WO2011060877A3 Materials for organic light emitting devices
03/29/2012US20120077974 Redox drug derivatives
03/29/2012US20120077835 Formulations of rifaximin and uses thereof
03/29/2012US20120077795 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
03/29/2012US20120077759 3-3-Di-Substituted-Oxindoles as Inhibitors of Translation Initiation
03/29/2012US20120076857 Forms of rifaximin and uses thereof
03/28/2012EP2432779A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
03/28/2012CN102395588A Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
03/28/2012CN102391287A Levo-fluoroquinolone C3 bisazole methyl sulfide, preparation method and application thereof
03/28/2012CN102391251A Chemokine receptor antagonists
03/28/2012CN102391107A Method for preparing gallic acid quinolone drug salt and preparation method thereof
03/27/2012US8143463 Process for the preparation of delmopinol and derivatives thereof
03/27/2012US8143416 Alternative synthesis of renin inhibitors and intermediates thereof
03/27/2012US8143375 Aziridine aldehydes, aziridine-conjugated amino derivatives, aziridine-conjugated biomolecules and processes for their preparation
03/27/2012US8143271 Compounds and methods for kinase modulation, and indications therefor
03/27/2012US8142784 Antibody-drug conjugates and methods
03/27/2012CA2554642C Bicyclic carbonyl amino derivatives as chemokine receptor antagonists
03/27/2012CA2447091C Methods for the treatment and prevention of pain using stress-activated protein kinase
03/22/2012WO2012036233A1 Condensed heterocyclic derivative having melanine-concentrating hormone receptor antagonistic activity
03/22/2012WO2012035305A1 Bioactive alkaloids
03/22/2012WO2012035023A1 Triazine-oxadiazoles
03/22/2012WO2011149250A3 Tricarbonyl technetium-99m or rhenium-188 label ring rgd derivative, a preparation method thereof, and a pharmaceutical composition containing the derivative as an active ingredient for use in the diagnosis or treatment of angiogenesis-related diseases
03/22/2012US20120071657 Triazole compounds useful as protein kinase inhibitors
03/22/2012US20120071652 Novel Piperazines, Pharmaceutical Compositions and Methods of Use Thereof
03/22/2012US20120071527 Therapeutic compounds
03/22/2012US20120071459 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
03/22/2012US20120070409 Tetracyclic fused heterocyclic compound and use thereof as hcv polymerase inhibitor
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 220